Prednisolone Tablets
Formulation (FDF) · Tablets · 5mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Prednisolone Tablets
- Dosage Form
- Tablets
- Strength
- 5mg
- Therapy Area
- Oncology
- Indication
- Hypersensitivity; Asthma; Rheumatoid arthritis; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Systemic lupus erythematosus; Dermatomyositis; Malignant neoplasm; Adrenal insufficiency
- Current Status
- Official FDF licensing catalog (UB574)
- GMP Certification
- US - FDA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3004.903 customs bills on file
Registrable Markets
United States
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price